# EDGAR Filing Document

**Accession Number:** 0001841330
**File Stem:** 0001213900-25-113652
**Filing Date:** 2025-11
**Character Count:** 2056
**Document Hash:** 629452663783b0f257277ef55e02daa0
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001213900-25-113652.hdr.sgml**: 20260407

**ACCESSION NUMBER**: 0001213900-25-113652

**CONFORMED SUBMISSION TYPE**: CORRESP

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20251121

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Pasithea Therapeutics Corp.
- **CENTRAL INDEX KEY:** 0001841330
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 851591963
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** CORRESP

**BUSINESS ADDRESS:**
- **STREET 1:** 1111 LINCOLN ROAD, SUITE 500
- **CITY:** MIAMI BEACH
- **STATE:** FL
- **ZIP:** 33139
- **BUSINESS PHONE:** (702) 514-4174

**MAIL ADDRESS:**
- **STREET 1:** 1111 LINCOLN ROAD, SUITE 500
- **CITY:** MIAMI BEACH
- **STATE:** FL
- **ZIP:** 33139

November 21, 2025

**<u>VIA EDGAR</u>**

United States Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, D.C. 20549

Re: Pasithea Therapeutics Corp. (the "Company") <br> Registration Statement on Form S-1 (File No. 333-291611)

Ladies and Gentlemen:

In accordance with Rule 461 under the Securities Act of 1933, as amended, the Company hereby requests that the above-referenced Registration Statement (the "Registration Statement") be declared effective by the Securities and Exchange Commission at 9:00 a.m., Eastern Time, on November 24, 2025, or as soon as practicable thereafter.

The Company hereby authorizes James B. O'Grady of Lowenstein Sandler LLP, the Company's outside legal counsel, to orally modify or withdraw this request for acceleration.

Please call Mr. O'Grady of Lowenstein Sandler LLP at (646) 414-6849 to confirm the effectiveness of the Registration Statement or with any questions.

---

| | |
|:---|:---|
| Very truly yours, | Very truly yours, |
| PASITHEA THERAPEUTICS CORP. | PASITHEA THERAPEUTICS CORP. |
| By: | /s/ Dr. Tiago Reis Marques |
|  | Dr. Tiago Reis Marques |
|  | Chief Executive Officer |

---